A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical ...

chest pain or circulatory problems are confused with those of other heart and lung diseases. Because the chronically elevated blood pressure in the pulmonary circulation also puts a strain on the ...

Researchers are working to redefine diagnosis and treatment with data-driven tools aimed at identifying patients earlier and ...

The 18-meter walk test (18MWT) effectively evaluates disease severity and predicts clinical outcomes in pulmonary arterial ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

I graduated from the University of Edinburgh in 1991 and undertook a period of postgraduate research in Dundee examining the effects of hypoxia, hypercapnia and vasoactive peptides on the pulmonary ...